title: Prediction of relapse following treatment for hepatitis C: is whole blood more than the sum of its parts?
authors.forename: Norah
authors.initials: N
authors.lastname: Shire
authors.forename: Margaret James
authors.initials: MJ
authors.lastname: Koziel
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D006526:Hepatitis C / Q000097:blood* / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D012367:RNA, Viral / Q000097:blood* / Q000187:drug effects; D012008:Recurrence
chemical_list: D000998:Antiviral Agents; D012367:RNA, Viral; D007372:Interferons